Pfizer Corporation Hong Kong Limited 美國輝瑞科研製藥

metamucil_product

Indications¹

Management of chronic constipation, in irritable bowel syndrome, as adjunctive therapy in diverticular disease and constipation caused by antacid administration in duodenal ulcer; in the bowel management of patients with haemorrhoids; constipation during pregnancy, convalescence and senility. FDA-approved for lowering cholesterol lowering and heart health.

Clinical Evidence

Significantly lowered serum total and low density lipoprotein (LDL)-cholesterol concentrations when combined with a low-fat diet.²

Safety Profile¹

CI:	Intestinal obstruction, faecal impaction. Phenylketonuria (sugar-free powder).

SP:	Diabetes. Sudden change in bowel habits >2 weeks, abdominal pain, nausea, vomiting, chest pain, difficulty in swallowing, or rectal bleeding. Constipation >7 days.

AR:	People who are sensitive to inhaled or ingested psyllium may have an allergic reaction.

DI:	None known.

Dosages¹

Regular flavour powder: Adults 2 tsp, children 6–12 years old ½ adult dose. Orange flavour powder: Adults 3 tsp, children 6–12 years old ½ adult dose. Smooth texture orange (sugar-free) powder: Adults 1.5 tsp, children 6–12 years old ½ adult dose. Instant sachet pack, orange flavour (sugar-free + smooth texture): Adults 1 pack, children 6–12 years old ½ adult dose.

All to be taken with 250 mL (8 oz) cool water and stirred well. Regular flavour powder can also be taken with fruit juice, milk or other liquid.

Packing¹

Regular flavour powder 538 g/bottle. Orange flavour powder 538 g/bottle. Smooth texture orange (sugar-free) powder 283 g/bottle. Instant sachet pack, orange flavour (sugar free + smooth texture) x 30’s.

References

1. MIMS Annual Hong Kong. 2007/2008 edition.
2. Anderson JW, et al. Am J Clin Nutr 2000;71:472-479.

Please review the full product information or package insert before prescribing.